Goldman Sachs
NVO icon

Goldman Sachs’s Novo Nordisk NVO Stock Holding History

Goldman Sachs’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122M Buy
+2,554,600
New +$110M 0.01% 1089
2026
Q1 		– Sell
-1,575,000
Closed -$80.1M – 6840
2025
Q4 		$80.1M Sell
1,575,000
-1,227,400
-44% -$62.8M 0.01% 1143
2025
Q3 		$156M Buy
2,802,400
+2,488,800
+794% +$146M 0.02% 711
2025
Q2 		$21.6M Sell
313,600
-95,900
-23% -$6.52M ﹤0.01% 2058
2025
Q1 		$28.4M Buy
409,500
+389,600
+1,958% +$32.2M ﹤0.01% 1694
2024
Q4 		$1.71M Sell
19,900
-30,600
-61% -$3.31M ﹤0.01% 4417
2024
Q3 		$6.01M Sell
50,500
-85,700
-63% -$11.4M ﹤0.01% 3182
2024
Q2 		$19.4M Buy
136,200
+121,200
+808% +$16.1M ﹤0.01% 1911
2024
Q1 		$1.93M Buy
+15,000
New +$1.79M ﹤0.01% 3893
2021
Q1 		– Sell
-44,200
Closed -$1.54M – 6262
2020
Q4 		$1.54M Buy
+44,200
New +$1.53M ﹤0.01% 3916
2019
Q4 		– Sell
-312,000
Closed -$8.06M – 5352
2019
Q3 		$8.06M Buy
+312,000
New +$7.89M ﹤0.01% 2488
2019
Q1 		– Sell
-91,000
Closed -$2.1M – 5350
2018
Q4 		$2.1M Buy
+91,000
New +$2.02M ﹤0.01% 3500

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs's NVO Position: Q2 2026 in Review

Goldman Sachs increased its Novo Nordisk (NVO) stake by 79% in Q2 2026, buying an estimated $174M and bringing the position to 9,180,490 shares worth $440M. The position accounts for 0.04% of the portfolio, ranked #449.

Goldman Sachs first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $663M in Q1 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Goldman Sachs held 9,180,490 shares of Novo Nordisk worth $440M as of Q2 2026.
  • Goldman Sachs bought 4,059,453 Novo Nordisk shares in Q2 2026, an estimated $174M.
  • Novo Nordisk made up 0.04% of Goldman Sachs's portfolio in Q2 2026, its #449 holding.
  • Goldman Sachs first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Novo Nordisk position peaked at $663M in Q1 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.